Sonja studied biochemistry and medicine at the University of Hamburg where she received her PhD and MD. She is a board-certified hematologist and oncologist and is currently leading the thoracic and molecular oncology programs of the II. Medical Clinic. She is also responsible for the „National Network Genomic Medicine“ (nNGM) center at the UKE. In these areas, she is conducting Phase 1-3 clinical trials and coordinating translational research programs with a focus on targeted therapies and liquid biopsies.
Sonja completed her Post-Doctoral training in the laboratory of Peter Carmeliet (Leuven) and is heading the Personalized Oncology Lab since 2010. She is holding a Heisenberg Professorship from the German Research Council (DFG) since 2016 and receives research funding from prestigious funding bodies including the European Research Council (ERC), the German Cancer Aid (Deutsche Krebshilfe), the Landesexzellenzstiftung Hamburg and the DFG. Sonja is participating in different collaborative research projects: the Schwerpunktprogramm (SPP ) µBone on malignant colonization of bone (DFG funded), the National Network Genomic Medicine on molecular diagnostic and therapy in non-small cell lung cancer (DKH funded) and in a consortium on sex differences in infection, autoimmunity and cancer (funded by Landesexzellenzstiftung Hamburg).
Sonja is supervising students from life sciences and medicine at different levels: bachelor thesis, master thesis, MD thesis, PhD thesis, clinician scientists and internships. She is a mentor in the mentorship program for excellent medical students, serves in the “Prüfungssausschuss” of the UKE and in the management board of the novel Mildred Scheel Nachwuchszentrum (MSZN ) funded by the DKH.